Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period (2006)
Abraham, John (Author)
Davis, Courtney (Author)
Social History of Medicine
Volume: 19
Pages: 127--147
This article analyses how practolol, the first British drug disaster of the modern, post-thalidomide regulatory period, related to the pharmaceutical industry, the medical profession and government regulation of patients' health. Drawing on comparison with the USA, it argues that, contrary to public expectation and perception, the aftermath of thalidomide did not give rise to strident British drug control, imposing the highest possible safety standards on the pharmaceutical industry. Rather, there existed a culture of reluctant regulation that was characterised by continued optimism about, and trust in the purported benefits of new drugs among manufacturers and regulators in the United Kingdom, together with commitment to the protection of the industry and its institutional support for the medical profession. In particular, British regulators were willing to allow new drugs on to the market, fully aware of uncertainty about their safety, but unwilling to be pro-active in issuing warning letters about risks and requiring `certainty' before acting to withdraw a product. Even after the practolol disaster, the British system was unable to reform itself to construct more rigorous and pro-active monitoring of drug risks. This was because of conflicts with industry interests.
...MoreSimilar Citations
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Chapter
Daemmrich, A.;
Greene, J.;
(2010)
From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance
(/isis/citation/CBB001221031/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Article
Abraham, John;
Davis, Courtney;
(2009)
Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation
(/isis/citation/CBB000953573/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/isis/citation/CBB001220743/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/isis/citation/CBB001221029/)
Article
Tobbell, Dominique A.;
(2008)
Allied against Reform: Pharmaceutical Industry--Academic Physician Relations in the United States, 1945--1970
(/isis/citation/CBB000930716/)
Article
Daemmrich, A.;
(2007)
Pharmaceutical Regulation in the United States and Europe
(/isis/citation/CBB001221028/)
Article
Anderson, Stuart;
(2008)
From “Bespoke” to “Off-the-Peg”: Community Pharmacists and the Retailing of Medicines in Great Britain 1900 to 1970
(/isis/citation/CBB000932017/)
Article
Quirke, Viviane;
(2006)
Putting Theory into Practice: James Black, Receptor Theory and the Development of the Beta-Blockers at ICI, 1958--1978
(/isis/citation/CBB000773951/)
Article
Klöppel, Ulrike;
Balz, Viola;
(2010)
Psychopharmaka im Sozialismus. Arzneimittelregulierung in der Deutschen Demokratischen Republik in den 1960er Jahren
(/isis/citation/CBB001022054/)
Article
Herzberg, David;
(2011)
Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America
(/isis/citation/CBB001221531/)
Article
Pieters, Toine;
Majerus, Benoît;
(2011)
The Introduction of Chlorpromazine in Belgium and the Netherlands (1951--1968); Tango between Old and New Treatment Features
(/isis/citation/CBB001221534/)
Article
Kuo, Wen-Hua;
(2009)
The Voice on the Bridge: Taiwan's Regulatory Engagement with Global Pharmaceuticals
(/isis/citation/CBB001021062/)
Article
Balz, Viola;
Hoheisel, Matthias;
(2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970
(/isis/citation/CBB001221535/)
Article
Horwitz, Allan V.;
(2011)
Naming the Problem That Has No Name: Creating Targets for Standardized Drugs
(/isis/citation/CBB001221532/)
Thesis
Hanganu-Bresch, Cristina;
(2008)
Faces of Depression: A Study of Antidepressant Advertisements in the American and British Journals of Psychiatry, 1960--2004
(/isis/citation/CBB001561430/)
Article
Abraham, John;
Davis, Courtney;
(2010)
Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977--1986
(/isis/citation/CBB000932837/)
Be the first to comment!